Final report of University Hospital Hradec Kralove to the clinical trial protocol no. GS-US-312-0115
Abstract
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)